Skip to main content
. 2021 Jul 30;14:943–954. doi: 10.2147/JAA.S315678

Table 4.

Odds Ratios for Overall Disease Control (Unadjusted and Adjusted) and Respective 95% Confidence Intervals

Variable Unadjusted OR (95% CI) Adjusted* OR (95% CI)
Number of days with SABA use in the previous 4 weeks
 ≤ 8 days
 > 8 days 2.9 (1.5–5.6) 2.6 (1.3–5.2)
History of exacerbations requiring OCS prescription for at least 3 days, in the last 12 months
 No
 Yes 3.2 (1.5–6.6) 3.0 (1.3–6.6)

Notes: *Adjusted for sociodemographic variables, BMI, smoking history, therapeutic regimen, comorbidities, number of packages purchased in the last 3 months, average number of SABA uses per day, maximum number of SABA uses in a 24-hour period, medical specialty of asthma-related doctors’ appointments, history of exacerbation ED visit in the previous 12 months or requiring hospital admission for at least one night in the previous 12 months.

Abbreviations: OCS, oral corticosteroid; SABA, Short-acting β2-agonists.